IA
WST icon

IndexIQ Advisors’s West Pharmaceutical WST Stock Holding History

IndexIQ Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.85M Sell
9,376
-2,226
-19% -$871K 0.14% 153
2021
Q4 		$5.44M Buy
11,602
+221
+2% +$95.1K 0.18% 91
2021
Q3 		$4.83M Sell
11,381
-90
-0.8% -$37.9K 0.16% 105
2021
Q2 		$4.12M Sell
11,471
-291
-2% -$96.1K 0.14% 112
2021
Q1 		$3.31M Buy
11,762
+10,735
+1,045% +$3.07M 0.12% 141
2020
Q4 		$291K Buy
+1,027
New +$288K 0.01% 694

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

IndexIQ Advisors's WST Position: Q1 2022 in Review

IndexIQ Advisors reduced its West Pharmaceutical (WST) stake by 19% in Q1 2022, selling an estimated $871K and leaving 9,376 shares worth $3.85M. The position accounts for 0.14% of the portfolio, ranked #153.

IndexIQ Advisors first reported a position in WST in Q4 2020 and has held it in 6 quarters since. The position peaked at $5.44M in Q4 2021. 716 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • IndexIQ Advisors held 9,376 shares of West Pharmaceutical worth $3.85M as of Q1 2022.
  • IndexIQ Advisors sold 2,226 West Pharmaceutical shares in Q1 2022, an estimated $871K.
  • West Pharmaceutical made up 0.14% of IndexIQ Advisors's portfolio in Q1 2022, its #153 holding.
  • IndexIQ Advisors first reported a position in West Pharmaceutical in Q4 2020 and has held it in 6 quarters since.
  • IndexIQ Advisors's West Pharmaceutical position peaked at $5.44M in Q4 2021.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.